23 Nov

Application for quotation of securities - PXS

Application for quotation of +securities Application for quotation of +securities 1 / 5 Announcement Summary Entity name PHARMAXIS LTD Announcement Type New announcement Date of this announcement Tuesday November 23, 2021 The +securities to be quoted are: Total number of +securities to be quoted ASX +security code Security description Number of +securities to be quoted Issue date PXS ORDINARY FULLY PAID 58,636,282 24/11/2021 Refer to next page for full details of the announcement +Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B Application for quotation of +securities Application for quotation of +securities 2 / 5 Part 1 - Entity and announcement details 1.1 Name of entity PHARMAXIS LTD We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules. 1.2 Registered number type ABN Registration number 75082811630 1.3 ASX issuer code PXS 1.4 The announcement is 1.5 Date of this announcement 23/11/2021 New announcement Application for quotation of +securities Application for quotation of +securities 3 / 5 Part 2 - Type of Issue 2.1 The +securities to be quoted are: Previous Appendix 3B details: Announcement Date and Time 17-Nov-2021 10:13 Announcement Title New - Proposed issue of securities - PXS Selected Appendix 3B to submit quotation request A placement or other type of issue 2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B? 2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B 9,523,810 ordinary fully paid shares expected to be issued on or before 25 November 2021 Yes +Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B Application for quotation of +securities Application for quotation of +securities 4 / 5 Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B Placement Details ASX +security code and description PXS : ORDINARY FULLY PAID Issue date 24/11/2021 Issue details Number of +securities to be quoted 58,636,282 Are the +securities being issued for a cash consideration? In what currency is the cash consideration being paid? AUD - Australian Dollar What is the issue price per +security? AUD 0.10500000 Any other information the entity wishes to provide about the +securities to be quoted Yes Application for quotation of +securities Application for quotation of +securities 5 / 5 Part 4 - Issued capital following quotation Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise: (A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.) 4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application) ASX +security code and description Total number of +securities on issue PXS : ORDINARY FULLY PAID 513,036,896 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue PXSAG : OPTION EXPIRING 28-JUN-2022 EX NIL PRICE 77,000 PXSAAP : OPTION EXPIRING 06-JUN-2023 EX NIL PRICE 66,500 PXSAAS : PERFORMANCE RIGHTS 24,268,350
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Pharmaxis Ltd (ASX:PXS) when you join Listcorp.